Back
Royalty Pharma PLC Stock Price Chart
This A.I. system is like having 100k financial analysts on hand
Get here to get the full story
Sell
50
RPRX
Royalty Pharma PLC
Last Price:
30.28
Seasonality Move:
1.47%
7 Day Trial
ALL ACCESS PASS
$
7
Prepare now for a ChatGPT IPO announcement
Click here to see more- The current trend is relatively stagnant and RPRX is experiencing slight selling pressure.
Royalty Pharma PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.13 | Buy |
| 20-day SMA: | 30.07 | Buy |
| 50-day SMA: | 30.46 | Sell |
| 200-day SMA: | 35.36 | Sell |
| 8-day EMA: | 30.13 | Buy |
| 20-day EMA: | 30.18 | Buy |
| 50-day EMA: | 30.78 | Sell |
| 200-day EMA: | 34.43 | Sell |
Royalty Pharma PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 49.8 | Sell |
| Chaikin Money Flow: | -331607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.69 - 30.75) | Buy |
| Bollinger Bands (100): | (30.12 - 34.36) | Sell |
Royalty Pharma PLC Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
- Royalty Pharma PLC share price is 30.27 while RPRX 8-day simple moving average is 30.13, which is a Buy signal.
- The stock price of RPRX is 30.27 while Royalty Pharma PLC 20-day SMA is 30.07, which makes it a Buy.
- Royalty Pharma PLC 50-day simple moving average is 30.46 while RPRX share price is 30.27, making it a Sell technically.
- RPRX stock price is 30.27 and Royalty Pharma PLC 200-day simple moving average is 35.36, creating a Sell signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
50
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a Sell
The current Royalty Pharma PLC [RPRX] share price is $30.27. The Score for RPRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
13.59B
Price in USD:
30.27
Share Volume:
1.71M
Royalty Pharma PLC 52-Week Range
52-Week High:
44.47
52-Week Low:
28.98
Sell
50
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?
The Royalty Pharma PLC stock price is 30.27 USD today. -
Will RPRX stock go up or go down?
Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Royalty Pharma PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
- Royalty Pharma PLC share price is 30.27 while RPRX 8-day exponential moving average is 30.13, which is a Buy signal.
- The stock price of RPRX is 30.27 while Royalty Pharma PLC 20-day EMA is 30.18, which makes it a Buy.
- Royalty Pharma PLC 50-day exponential moving average is 30.78 while RPRX share price is 30.27, making it a Sell technically.
- RPRX stock price is 30.27 and Royalty Pharma PLC 200-day simple moving average is 34.43, creating a Sell signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.19 per share, an increase this year of $0.50 per share, and a decrease next year of $0.23 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
- RPRX Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Royalty Pharma PLC is a Sell
- Royalty Pharma PLC Relative Strength Index (RSI) is 49.8, which suggest Royalty Pharma PLC is oversold
- The Bollinger Bands (25) for Royalty Pharma PLC is (29.69 - 30.75), which suggest Royalty Pharma PLC is a Sell
- The Bollinger Bands (100) for Royalty Pharma PLC is (30.12 - 34.36), which suggest Royalty Pharma PLC is a Sell
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.